株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

体外毒性検査市場規模、シェア、動向分析:技術別、手法別(セルラーアッセイ、バイオケミカルアッセイ、インシリカ、Ex-vivo)、用途別、エンドユース別、地域別動向、セグメント予測

In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, High Throughput), By Method, By Application, By End Use, By Region, And Segment Forecasts, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 656141
出版日 ページ情報 英文 100 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。
体外毒性検査市場規模、シェア、動向分析:技術別、手法別(セルラーアッセイ、バイオケミカルアッセイ、インシリカ、Ex-vivo)、用途別、エンドユース別、地域別動向、セグメント予測 In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, High Throughput), By Method, By Application, By End Use, By Region, And Segment Forecasts, 2020 - 2027
出版日: 2020年02月13日 ページ情報: 英文 100 Pages
概要

当レポートでは、世界の体外毒性検査市場について調査し、市場の現状と成長予測、技術別、手法別、用途別、エンドユース別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 調査方法

第3章 市場変数、動向、範囲

  • 市場セグメンテーションと範囲
    • 促進因子分析
    • 阻害因子分析
  • 浸透度と成長見通しマッピング
  • SWOT分析
  • 業界分析

第4章 技術別市場と動向分析

  • 動向分析
  • 細胞培養技術
  • ハイスループット技術
  • 分子画像
  • OMICS技術

第5章 手法別予測と動向分析

  • 動向分析
  • セルラーアッセイ
  • バイオケミカルアッセイ
  • インシリコ
  • Ex-vivo

第6章 用途別予測と動向分析

  • 動向分析
  • 全身毒性
  • 皮膚毒性
  • 内分泌かく乱
  • 細胞毒性

第7章 エンドユース別予測と動向分析

  • 動向分析
  • 製薬業界

第8章 地域別予測と動向分析

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合環境

  • 戦略枠組み
  • 市場参入分類
  • 企業プロファイル
    • Agilent Technologies Inc.
    • Abbott
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Charles River Laboratories International, Inc.
    • Thermo Fisher Scientific Inc.
    • Catalent, Inc.
    • Eurofins Scientific.
    • GE Healthcare.
    • Quest Diagnostics Incorporated
    • LabCorpR
    • EVOTEC
図表

List of Tables

  • TABLE 1 North America in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 2 North America in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 3 North America in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 4 North America in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 5 U.S. in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 6 U.S. in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 7 U.S. in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 8 U.S. in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 9 Canada in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 10 Canada in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 11 Canada in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 12 Canada in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 13 Europe in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 14 Europe in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 15 Europe in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 16 Europe in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 17 Germany in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 18 Germany in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 19 Germany in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 20 Germany in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 21 U.K. in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 22 U.K. in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 23 U.K. in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 24 U.K. in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 25 Asia Pacific in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 26 Asia Pacific in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 27 Asia Pacific in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 28 Asia Pacific in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 29 Japan in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 30 Japan in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 31 Japan in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 32 Japan in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 33 China in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 34 China in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 35 China in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 36 China in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 37 Latin America in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 38 Latin America in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 39 Latin America in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 40 Latin America in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 41 Brazil in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 42 Brazil in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 43 Brazil in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 44 Brazil in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 45 MEA in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 46 MEA in-vitro toxicology testing market estimates and forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 47 MEA in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 48 MEA in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
  • TABLE 49 South Africa in-vitro toxicology testing market estimates and forecasts, by technology 2016 - 2027 (USD Million)
  • TABLE 50 South Africa in-vitro toxicology testing market forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 51 South Africa in-vitro toxicology testing market estimates and forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 52 South Africa in-vitro toxicology testing market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)

List of Figure

FIG. 1 Market segmentation & scope

FIG. 2 Market summary (USD Million)

FIG. 3 Market research process

FIG. 4 Information procurement

FIG. 5 Primary research pattern

FIG. 6 Market research approaches

FIG. 7 Value chain based sizing & forecasting

FIG. 8 QFD modelling for market share assessment

FIG. 9 Industry pyramid analysis

FIG. 10 Penetration & growth prospect mapping for application, 2019

FIG. 11 Market trends & outlook

FIG. 12 Market driver relevance analysis (Current & future impact)

FIG. 13 Various factors that are driving trend of non-animal technologies

FIG. 14 Market restraint relevance analysis (Current & future impact)

FIG. 15 SWOT Analysis, By Factor (political & legal, economic and technological)

FIG. 16 Porter's Five Forces Analysis

FIG. 17 In-vitro toxicology testing market: Technology outlook key takeaways

FIG. 18 In-vitro toxicology testing market: Technology movement analysis

FIG. 19 Global cell culture technology market, by revenue 2016 - 2027 (USD Million)

FIG. 20 Global high-throughput technology market, by revenue 2016 - 2027 (USD Million)

FIG. 21 Global molecular imaging market, by revenue 2016 - 2027 (USD Million)

FIG. 22 Global OMICS technology market, by revenue 2016 - 2027 (USD Million)

FIG. 23 In-vitro toxicology testing market: Method outlook key takeaways

FIG. 24 In-vitro toxicology testing market: Method movement analysis

FIG. 25 Global cellular assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)

FIG. 26 Global biochemical assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)

FIG. 27 Global in silico assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)

FIG. 28 Global ex vivo assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)

FIG. 29 In-vitro toxicology testing market: Application outlook key takeaways

FIG. 30 In-vitro toxicology testing market: Application movement analysis

FIG. 31 Global systemic toxicology market, 2016 - 2027 (USD Million)

FIG. 32 Global dermal toxicology market, 2016 - 2027 (USD Million)

FIG. 33 Global endocrine disruption market, 2016 - 2027 (USD Million)

FIG. 34 Global ocular toxicity market, 2016 - 2027 (USD Million)

FIG. 35 Global other applications market, 2016 - 2027 (USD Million)

FIG. 36 In-vitro toxicology testing market: End-use outlook key takeaways

FIG. 37 In-vitro toxicology testing market: End-use movement analysis

FIG. 38 Global pharmaceutical industry market, 2016 - 2027 (USD Million)

FIG. 39 Global cosmetics & household products market, 2016 - 2027 (USD Million)

FIG. 40 Global diagnostics market, 2016 - 2027 (USD Million)

FIG. 41 Global chemical industry market, 2016 - 2027 (USD Million)

FIG. 42 Global food industry market, 2016 - 2027 (USD Million)

FIG. 43 Regional market place: Key takeaways

FIG. 44 In-vitro toxicology testing market regional outlook, 2019 & 2027

FIG. 45 North America in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 46 U.S. in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 47 Canada in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 48 Europe in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 49 Germany in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 50 U.K. in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 51 Asia Pacific in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 52 China in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 53 Japan in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 54 Latin America in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 55 Brazil in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 56 Middle East & Africa in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 57 South Africa in-vitro toxicology testing market, 2016 - 2027 (USD Million)

FIG. 58 Participant categorization

FIG. 59 Impact analysis by key companies

FIG. 60 Market position analysis for public companies

FIG. 61 Strategy framework"

目次
Product Code: 978-1-68038-847-3

The global in-vitro toxicology testing market size is anticipated to reach USD 30.9 billion by 2027 and is projected to register a CAGR of 9.2% over the forecast period, according to a new report by Grand View Research, Inc. The new paradigm shift in toxicity testing of animal models toward computational methods such as silico models to interpret toxicity pathway data, drives the demand for in-vitro toxicology testing. These methods provide cost and time efficiency and enhance safety assessment.

Several governments are taking measures to minimize animal-based test models, forming conducive government policies, and providing funds to support in-vitro models. These factors are expected to create ample growth opportunities for the market. For instance, in November 2019, the U.S. National Institute for Environmental Health Sciences planned to provide funds to small companies for the development of engineered 3D culture or organotypic culture models (OCM) in-vitro systems.

With advancements in high throughput screening, biological screening, and chemical synthesis, the number of publicly available databases containing data related to toxicity; absorption, distribution, metabolism, and excretion (ADME); pharmacovigilance; and drug screening has expanded rapidly. This has enabled scientists to access vast information for toxicity profiling, thereby spurring revenue generation in this market.

Further key findings from the report suggest:

  • Growing application of 3D-spheroid-cultures, particularly for nanoparticle toxicity testing, resulted in the dominance of the cell culture technology segment in 2019
  • Omics technology is anticipated to register lucrative growth as RNA sequencing and shotgun proteomics are increasingly used for a more comprehensive understanding of the effects of toxicants
  • The high usage rate of cellular assays with advancements in cell-based technologies, including label-free detection and high-content screening, has contributed to the dominance of the cellular assays segment in 2019
  • Systemic toxicology emerged as the leading application segment in 2019 as it plays a key role in risk assessment during drug development procedures. For instance, toxicity testing of systemic immunosuppressive drugs and systemic corticosteroids is important during the development of drugs for ocular inflammatory disease
  • Pharmaceutical industry dominated the in-vitro toxicology testing market in 2019 as toxicological testing is a prerequisite step for drug development
  • Stringent government regulations regarding animal usage for toxicity analysis in North America have led to an increased adoption rate of in-vitro models. Hence, North America dominated the global market in 2019
  • The Asia Pacific region is anticipated to witness the fastest growth rate over the forecast period due to increasing initiatives by public agencies to encourage acceptance of non-animal test models

Abbott, Thermo Fisher, Agilent Technologies, GE Healthcare, Bio-Rad, and Merck KGaA are some of the key players operating in the market.

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Outlook
  • 1.2 In-vitro Toxicology Testing Market: Segment Outlook
  • 1.3 In-vitro Toxicology Testing Market: Competitive Insights

Chapter 2 Research Methodology

  • 2.1 Information Procurement
  • 2.2 Information or Data Analysis
  • 2.3 Market Formulation & Validation

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
  • 3.2 Penetration & Growth Prospect Mapping For Application, 2019
  • 3.3 In-vitro Toxicology Testing Market: Cost Structure Analysis
  • 3.4 In-vitro Toxicology Testing Market: Technology Overview
  • 3.5 In-vitro Toxicology Testing Market: Market Dynamics
    • 3.5.1 Market driver analysis
      • 3.5.1.1 Rise in government funding for toxicology research
      • 3.5.1.2 Opposition to animal testing
      • 3.5.1.3 Ongoing developments to advance toxicology research
    • 3.5.2 Market restraint analysis
      • 3.5.2.1 Lack of in-vitro models
      • 3.5.2.2 Issues pertaining to standardization of in-vitro studies
  • 3.6 In-vitro Toxicology Testing - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.7 Industry Analysis - Porter's

Chapter 4 Market Categorization: Technology Estimates & Trend Analysis

  • 4.1 In-vitro toxicology testing Market: Technology Movement Analysis, 2019 & 2027
  • 4.2 Cell Culture Technology
    • 4.2.1 Global cell culture technology market, by revenue 2016 - 2027 (USD Million)
  • 4.3 High-Throughput Technology (HTT)
    • 4.3.1 Global high-throughput technology market, by revenue 2016 - 2027 (USD Million)
  • 4.4 Molecular imaging
    • 4.4.1 Global molecular imaging market, by revenue 2016 - 2027 (USD Million)
  • 4.5 OMICS technology
    • 4.5.1 Global OMICS technology market, by revenue 2016 - 2027 (USD Million)

Chapter 5 Market Categorization: Method Estimates & Trend Analysis

  • 5.1 In-vitro toxicology testing Market: Method Movement Analysis
  • 5.2 Cellular Assays
    • 5.2.1 Global cellular assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
  • 5.3 Biochemical Assays
    • 5.3.1 Global biochemical assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
  • 5.4 In Silico
    • 5.4.1 Global in silico assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
  • 5.5 Ex Vivo
    • 5.5.1 Global ex vivo assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)

Chapter 6 Market Categorization: Application Estimates & Trend Analysis

  • 6.1 In-vitro Toxicology Testing Market: Application Movement Analysis
  • 6.2 Systemic Toxicology
    • 6.2.1 Global systemic toxicology market, 2016 - 2027 (USD Million)
  • 6.3 Dermal Toxicity
    • 6.3.1 Global dermal toxicity market, 2016 - 2027 (USD Million)
  • 6.4 Endocrine Disruption
    • 6.4.1 Global endocrine disruption market, 2016 - 2027 (USD Million)
  • 6.5 Ocular Toxicity
    • 6.5.1 Global ocular toxicity market, 2016 - 2027 (USD Million)
  • 6.6 Other Applications
    • 6.6.1 Global other applications market, 2016 - 2027 (USD Million)

Chapter 7 Market Categorization: End-use Estimates & Trend Analysis

  • 7.1 In-vitro Toxicology Testing Market: End-use Movement Analysis
  • 7.2 Pharmaceutical Industry
    • 7.2.1 Global pharmaceutical industry market, 2016 - 2027 (USD Million)
  • 7.3 Cosmetics & Household Products
    • 7.3.1 Global cosmetics & household products market, 2016 - 2027 (USD Million)
  • 7.4 Diagnostics
    • 7.4.1 Global diagnostics market, 2016 - 2027 (USD Million)
  • 7.5 Chemical Industry
    • 7.5.1 Global chemical industry market, 2016 - 2027 (USD Million)
  • 7.6 Food Industry
    • 7.6.1 Global food industry market, 2016 - 2027 (USD Million)

Chapter 8 Market Categorization: Regional Estimates & Trend Analysis, by End-use, Application, Method, & Technology

  • 8.1 In-vitro Toxicology Testing Market Share By Region, 2019 & 2027
  • 8.2 North America
    • 8.2.1 North America in-vitro toxicology testing market, 2016 - 2027 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
      • 8.2.2.2 U.S. in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
      • 8.2.2.3 U.S. in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
      • 8.2.2.4 U.S. in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
      • 8.2.3.2 Canada in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
      • 8.2.3.3 Canada in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
      • 8.2.3.4 Canada in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe in-vitro toxicology testing market, 2016 - 2027 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
      • 8.3.2.2 Germany in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
      • 8.3.2.3 Germany in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
      • 8.3.2.4 Germany in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
      • 8.3.3.2 U.K. in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
      • 8.3.3.3 U.K. in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
      • 8.3.3.4 U.K. in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific in-vitro toxicology testing market, 2016 - 2027 (USD Million)
    • 8.4.2 China
      • 8.4.2.1 China in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
      • 8.4.2.2 China in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
      • 8.4.2.3 China in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
      • 8.4.2.4 China in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
    • 8.4.3 Japan
      • 8.4.3.1 Japan in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
      • 8.4.3.2 Japan in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
      • 8.4.3.3 Japan in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
      • 8.4.3.4 Japan in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America in-vitro toxicology testing market, 2016 - 2027 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
      • 8.5.2.2 Brazil in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
      • 8.5.2.3 Brazil in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
      • 8.5.2.4 Brazil in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Middle East & Africa in-vitro toxicology testing market, 2016 - 2027 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa in-vitro toxicology testing market, by technology, 2016 - 2027 (USD Million)
      • 8.6.2.2 South Africa in-vitro toxicology testing market, by method, 2016 - 2027 (USD Million)
      • 8.6.2.3 South Africa in-vitro toxicology testing market, by application, 2016 - 2027 (USD Million)
      • 8.6.2.4 South Africa in-vitro toxicology testing market, by end-use, 2016 - 2027 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Market Participation Categorization
  • 9.2 Recent Developments & Impact Analysis, by Key Market Participants
  • 9.3 Public Companies
    • 9.3.1 Company market position analysis
  • 9.4 Private Companies
    • 9.4.1 List of key emerging companies/ innovators
  • 9.5 Strategy Framework
  • 9.6 Company Profiles
    • 9.6.1 Agilent Technologies
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product Benchmarking
      • 9.6.1.4 Strategic initiatives
    • 9.6.2 Abbott
      • 9.6.2.1 Company overview
      • 9.6.2.1.1 Alere Inc.
      • 9.6.2.2 Financial performance
      • 9.6.2.2.1 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 Bio-Rad Laboratories, Inc.
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 Merck KGaA
      • 9.6.4.1 Company overview
      • 9.6.4.1.1 BioReliance Corporation
      • 9.6.4.1.2 Sigma Aldrich, Inc.
      • 9.6.4.2 Financial performance
      • 9.6.4.2.1 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 Charles River
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic initiatives
    • 9.6.6 Thermo Fisher Scientific Inc.
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic initiatives
    • 9.6.7 Catalent, Inc.
      • 9.6.7.1 Company overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product benchmarking
      • 9.6.7.4 Strategic initiatives
    • 9.6.8 Eurofins Scientific
      • 9.6.8.1 Company overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 GE Healthcare
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 Quest Diagnostics Incorporated
      • 9.6.10.1 Company overview
      • 9.6.10.2 Financial performance
      • 9.6.10.3 Product benchmarking
      • 9.6.10.4 Strategic initiatives
    • 9.6.11 Laboratory Corporation of America Holdings
      • 9.6.11.1 Company overview
      • 9.6.11.1.1 Covance Inc.,
      • 9.6.11.2 Financial performance
      • 9.6.11.3 Product benchmarking
      • 9.6.11.4 Strategic initiatives
    • 9.6.12 Evotec
      • 9.6.12.1 Company overview
      • 9.6.12.1.1 Cyprotex
      • 9.6.12.2 Financial performance
      • 9.6.12.3 Product benchmarking
      • 9.6.12.4 Strategic initiatives
    • 9.6.13 Creative Bioarray
      • 9.6.13.1 Company overview
      • 9.6.13.2 Financial performance
      • 9.6.13.3 Product benchmarking
      • 9.6.13.4 Strategic initiatives
    • 9.6.14 Gentronix
      • 9.6.14.1 Company overview
      • 9.6.14.2 Financial performance
      • 9.6.14.3 Product benchmarking
      • 9.6.14.4 Strategic initiatives
    • 9.6.15 HD Biosciences Co., Ltd.
      • 9.6.15.1 Company overview
      • 9.6.15.2 Financial performance
      • 9.6.15.3 Product benchmarking
      • 9.6.15.4 Strategic initiatives
    • 9.6.16 MB Research Laboratories
      • 9.6.16.1 Company overview
      • 9.6.16.2 Financial performance
      • 9.6.16.3 Product benchmarking
      • 9.6.16.4 Strategic initiatives
    • 9.6.17 BioIVT
      • 9.6.17.1 Company overview
      • 9.6.17.2 Financial performance
      • 9.6.17.3 Product benchmarking
      • 9.6.17.4 Strategic initiatives
    • 9.6.18 SGS SA
      • 9.6.18.1 Company overview
      • 9.6.18.2 Financial performance
      • 9.6.18.3 Product benchmarking
      • 9.6.18.4 Strategic initiatives
    • 9.6.19 GVK Biosciences Private Limited
      • 9.6.19.1 Company overview
      • 9.6.19.2 Financial performance
      • 9.6.19.3 Product benchmarking
      • 9.6.19.4 Strategic initiatives
    • 9.6.20 InSphero
      • 9.6.20.1 Company overview
      • 9.6.20.2 Financial performance
      • 9.6.20.3 Product benchmarking
      • 9.6.20.4 Strategic initiatives